FDA Approved: XELSTRYM — Original Application (Noven Therapeutics, LLC)

View source ↗

Summary

FDA approved XELSTRYM (dextroamphetamine) under an Original New Drug Application by Noven Therapeutics, LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Attention Deficit Hyperactivity Disorder

Drugs mentioned

• XELSTRYM (Dextroamphetamine)

Snippet

ORIG AP for XELSTRYM (DEXTROAMPHETAMINE)